use of a compound to treat or prevent a bradykinin b2 receptor mediated angioedema and formulation comprising the same

摘要

methods of treatment of bradykinin b2 receptor-mediated angioedema methods of treatment of bradykinin b2 receptor-mediated angioedema in a subject by administering a composition containing an 8- (heteroarylmethoxy) quinolone compound, a compound of 8- (arylmethoxy) quinoline, or a salt, stereoisomer, hydrate, or solvate thereof. oral formulations containing an 8- (heteroarylmethoxy) quinolone compound, an 8- (arylmethoxy) quinoline compound, or a salt, stereoisomer, hydrate, or solvate thereof for the treatment of bradykinin b2 receptor mediated angioedema. use of a composition containing a composition containing an 8- (heteroarylmethoxy) quinolone compound, an 8- (arylmethoxy) quinoline compound, or a salt, a stereoisomer, a hydrate, or a solvate thereof for the manufacture of a medicament for treating and / or preventing a bradykinin b2 receptor mediated angioedema.